We’re pushing the limits of genetic medicine. And our goal is no limits.
Location: United States, Massachusetts, Cambridge
Total raised: $210M
Investors 2
| Date | Name | Website |
| - | Foresite C... | foresiteca... |
| - | Atlas Vent... | atlasventu... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 12.01.2020 | Series C | $110M | - |
| 27.02.2018 | Series B | $100M | - |
Mentions in press and media 12
| Date | Title | Description | Source |
| 06.03.2024 | Generation Bio Reports Business Highlights and Fourth Quarte... | - | globenewsw... |
| 12.05.2021 | GENERATION BIO CO. Generation Bio Presents Preclinical Data... | Durable, therapeutically relevant levels of anti-SARS-CoV-2 spike antibodies produced from the liver... | marketscre... |
| 01.04.2020 | Coronavirus Business Tracker: How The Private Sector Is Figh... | Alain Mérieux, founder of BioMérieux.AFP via Getty Images | forbes.com... |
| 12.01.2020 | Generation Bio Announces $110 Million Series C Financing | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Generation Bio, a company leading a new generation of gene therap... | citybizlis... |
| 10.01.2020 | Generation Bio grabs a $110M round to ramp up work on next-g... | In 2018, Generation Bio broke cover with a $25 million series A, swiftly followed by a meatier $100 ... | fiercebiot... |
| 10.01.2020 | Generation Bio Raises $110M in Series C Financing | Generation Bio, a Cambridge, MA-based gene therapy company, closed a $110m Series C financing. The r... | finsmes.co... |
| 10.01.2020 | Generation Bio Inks $110M Series C Financing | CAMBRIDGE, MA, Generation Bio announced the closing of a $110 million Series C financing. >>... | vcnewsdail... |
| 28.02.2018 | Term Sheet — Wednesday, February 28 | THE STATE OF PRIVATE EQUITY Good morning, Term Sheet readers. Paid Content What you need to know abo... | fortune.co... |
| 27.02.2018 | Generation Bio Raises $100M | CAMBRIDGE, MA, Generation Bio, a developer of genetic medicines, has secured $100 million in Serie... | vcnewsdail... |
| 27.02.2018 | Generation Bio raises $100M for ‘druglike’ gene therapy | Gene therapy startup Generation Bio has lost no time raising the resources it needs to take its prog... | fiercebiot... |
Show more